Merrill Lynch UK Inv Tst PLC
17 January 2002
MONTHLY PERFORMANCE
MERRILL LYNCH UK INVESTMENT TRUST plc
All information is at 31 December 2001 and unaudited.
Performance at month end with net income reinvested
One Three One Three Five
month months year years years
Net asset value -0.6% 10.4% -22.7% -13.3% 20.2%
Share price 1.9% 16.0% -22.2% -26.3% 9.1%
FTSE All-Share Index 0.5% 8.2% -13.3% 1.3% 42.4%
Sources: Merrill Lynch Investment Managers, Standard & Poor's Micropal
At month end
Net asset value* 909.96p
Share price: 815.00p
Discount: 10.4%
Total assets: £165.4m
Net Yield: 3.7%
Gearing: 31.3%
Effective gearing: 23.4%
Value of debt: £39.5m
Ordinary shares in issue: 13,868,562
(225,000 shares were repurchased and cancelled during the month)
*Includes current year net revenue of 1.97p
UK Sectors % Portfolio
Financials 26.2
Cyclical Services 17.6
Non-Cyclical Consumer Goods 14.6
Non-Cyclical Services 14.4
Resources 12.8
Information Technology 3.0
General Industrials 2.5
Basic Industries 2.2
Utilities 0.7
Cash 6.7
Net current liabilities (0.7)
Total 100.0
Ten Largest Equity Investments
Company
% Investments
BP Amoco 7.6
Vodafone 6.2
Barclays 6.1
GlaxoSmithKline 5.0
AstraZeneca 4.5
Royal Bank of Scotland 4.3
HSBC 4.1
BskyB 3.2
British Telecom 3.0
Amersham 2.9
Total 46.9
Market commentary
UK Stockmarket Review
The FTSE All Share Index rose by 0.5%, during a month of consolidation
following very strong performances in October and November.
Fund Performance Review
The Company's Net Asset Value (NAV) underperformed during December, falling by
0.6%.
The Trust benefited from the strong performance of the mining sector over the
month, in particular the holding in Lonmin, which rose strongly. Within
healthcare, Smith & Nephew aided performance, as the share continued to
perform well in recognition of strong earnings growth.
Performance was negatively impacted by the holding in BSkyB, which suffered
following a placing by one of its major shareholders, Vivendi Universal. The
equivalent of 8% of BSkyB's shares were placed, effectively saturating the
market. The shares were temporarily depressed, adversely affecting
performance, but have since recovered.
After reporting first half profits which were slightly short of market
expectations, spread betting company IG Group fell markedly. This adversely
affected Fund performance. We intend to maintain our holding, with the
expectation that the shares will recover.
Outlook
Although the near term outlook for the stockmarket remains uncertain, we
anticipate a recovery in the second half of 2002. We are slightly cautious
that the recent rally is sustainable, as investors have discounted a recovery
in the first half of the year. We anticipate that the market will pause for
breath at some point, providing further opportunities to increase our cyclical
exposure.
Latest information is available by typing www.mlim.co.uk/its on the internet,
'MLIMINDEX' on Reuters, 'MLIM' on Bloomberg or '8800' on Topic 3 (ICV
terminal).
17 January 2002
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.